Stokke C, Nørgaard JN, Feiring Phillips H, Sherwani A, Nuruddin S, Connelly J, Schjesvold F, Revheim ME(2022) Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients Mol Imaging Biol(in press) DOI 10.1007/s11307-022-01734-0, PubMed 35501622
Schjesvold FH, Bakker NA, Sonneveld P(2022) Melflufen in multiple myeloma: the conclusion matters - Authors' reply Lancet Haematol, 9(4), e244-e245 DOI 10.1016/S2352-3026(22)00071-0, PubMed 35358436
Schjesvold F, Richardson PG, Facon T, Alegre A, Spencer A, Jurczyszyn A, Sunami K, Frenzel L, Min CK, Guillonneau S, Lin PL, Le-Guennec S, Campana F, Van de Velde H, Bensfia S, Bringhen S(2022) Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis Haematologica, 107(3), 774-775 DOI 10.3324/haematol.2021.279160, PubMed 35229573